2[1]Suzuki T,Otak S,Naganuma S,et al. Clinical applications of fragmin (FR-860) in hemodialysis :multi center cooperative study in Japan. Seminals Thrombosis Hemostasis,1990;16 (suppl) : 46
3[2]Anastassiades E, Ireland H, Flynn A, et al. A lowmolecular-weight heparin (kabi 2165,Fragmin) in repeated use for hemodialysis: prevention of clotting and prolongation of the venous conpression time in comparison with commercial unfractionated heparin.Dial Transplant, 1990 ; 5 : 135
4[3]Shuichiro I,Masahiko N,Hidetade K. Study of anti coagulating mechansm of low molecular weight heparin.Thrombosis Research, 1992 ; 65 : 801
7[6]Wei SS, Ellis PW,Moetal M, et al. Effect of heparin modeling on delivered hemodialysis therapy. Am J Kid Dis,1994;23 : 389
8[7]Shaldon S,Koch KM. Survival and adequacy in longterm hemodialysis, Nephron, 1991 ; 59 : 353
9[8]Moia M,Graziani G. Rationale for the use of a lowmolecular weight heparin during hemodialysis with polysuphone membrane in uremic patients. Annals Italian MedicineInternational, 1997; 12(2) : 67
10[9]Hall AV, Clark WF, Parbtani A. Heparin-induced thrombocytopenia. Clinical Nephrology, 1992 ; 30: 86
